Sfoglia per Autore D'AGOSTINO, Mattia
Tracking genetically engineered lymphocytes long-term reveals the dynamics of t cell immunological memory
2015-01-01 Oliveira G.; Ruggiero E.; Stanghellini M.T.L.; Cieri N.; D'Agostino M.; Fronza R.; Lulay C.; Dionisio F.; Mastaglio S.; Greco R.; Peccatori J.; Aiuti A.; Ambrosi A.; Biasco L.; Bondanza A.; Lambiase A.; Traversari C.; Vago L.; Kalle C.V.; Schmidt M.; Bordignon C.; Ciceri F.; Bonini C.
Moving toward a tailored therapy in multiple myeloma
2016-01-01 D'Agostino M.; Palumbo A.
Plasma cell leukemia: update on biology and therapy
2017-01-01 Mina R.; D'Agostino M.; Cerrato C.; Gay F.; Palumbo A.
Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors
2017-01-01 Gay, Francesca; D'Agostino, Mattia; Giaccone, Luisa; Genuardi, Mariella; Festuccia, Moreno; Boccadoro, Mario; Bruno, Benedetto
Novel Immunotherapies for Multiple Myeloma
2017-01-01 D'Agostino M, Boccadoro M, Smith EL.
Novel investigational drugs active as single agents in multiple myeloma
2017-01-01 D'Agostino, Mattia; Salvini, Marco; Palumbo, Antonio; Larocca, Alessandra; Gay, Francesca
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN)
2018-01-01 Larocca, Alessandra*; Dold, Sandra Maria; Zweegman, Sonja; Terpos, Evangelos; Wäsch, Ralph; D’Agostino, Mattia; Scheubeck, Sophia; Goldschmidt, Hartmut; Gay, Francesca; Cavo, Michele; Ludwig, Heinz; Straka, Christian; Bringhen, Sara; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Offidani, Massimo; Dimopoulos, Meletios A.; Einsele, Hermann; Boccadoro, Mario; Sonneveld, Pieter; Engelhardt, Monika
CD38 as an immunotherapeutic target in multiple myeloma
2018-01-01 Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F.
Determining treatment intensity in elderly patients with multiple myeloma
2018-01-01 Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S.
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma
2018-01-01 Bringhen S.; D'Agostino M.; De Paoli L.; Montefusco V.; Liberati A.M.; Galieni P.; Grammatico S.; Muccio V.E.; Esma F.; De Angelis C.; Musto P.; Ballanti S.; Offidani M.; Petrucci M.T.; Gaidano G.; Corradini P.; Palumbo A.; Sonneveld P.; Boccadoro M.
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients
2018-01-01 Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
2018-01-01 D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F.
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma
2018-01-01 Oliva S.; Troia R.; D'Agostino M.; Boccadoro M.; Gay F.
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies
2019-01-01 D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F.
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
2019-01-01 Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M.
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma
2019-01-01 D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F.
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial
2019-01-01 Bringhen, Sara; D'Agostino, Mattia; Paris, Laura; Ballanti, Stelvio; Pescosta, Norbert; Spada, Stefano; Pezzatti, Sara; Grasso, Mariella; Rota-Scalabrini, Delia; De Rosa, Luca; Pavone, Vincenzo; Gazzera, Giulia; Aquino, Sara; Poggiu, Marco; Santoro, Armando; Gentile, Massimo; Baldini, Luca; Petrucci, Maria Teresa; Tosi, Patrizia; Marasca, Roberto; Cellini, Claudia; Palumbo, Antonio; Falco, Patrizia; Hájek, Roman; Boccadoro, Mario; Larocca, Alessandra
Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo
2019-01-01 Mattia D'Agostino; Mario Boccadoro
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT
2020-01-01 B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Tracking genetically engineered lymphocytes long-term reveals the dynamics of t cell immunological memory | 2015 | Oliveira G.; Ruggiero E.; Stanghellini M.T.L.; Cieri N.; D'Agostino M.; Fronza R.; Lulay C.; Dionisio F.; Mastaglio S.; Greco R.; Peccatori J.; Aiuti A.; Ambrosi A.; Biasco L.; Bondanza A.; Lambiase A.; Traversari C.; Vago L.; Kalle C.V.; Schmidt M.; Bordignon C.; Ciceri F.; Bonini C. | |
Moving toward a tailored therapy in multiple myeloma | 2016 | D'Agostino M.; Palumbo A. | |
Plasma cell leukemia: update on biology and therapy | 2017 | Mina R.; D'Agostino M.; Cerrato C.; Gay F.; Palumbo A. | |
Immuno-oncologic Approaches: CAR-T Cells and Checkpoint Inhibitors | 2017 | Gay, Francesca; D'Agostino, Mattia; Giaccone, Luisa; Genuardi, Mariella; Festuccia, Moreno; Boccadoro, Mario; Bruno, Benedetto | |
Novel Immunotherapies for Multiple Myeloma | 2017 | D'Agostino M, Boccadoro M, Smith EL. | |
Novel investigational drugs active as single agents in multiple myeloma | 2017 | D'Agostino, Mattia; Salvini, Marco; Palumbo, Antonio; Larocca, Alessandra; Gay, Francesca | |
Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN) | 2018 | Larocca, Alessandra*; Dold, Sandra Maria; Zweegman, Sonja; Terpos, Evangelos; Wäsch, Ralph; D’Agostino, Mattia; Scheubeck, Sophia; Goldschmidt, Hartmut; Gay, Francesca; Cavo, Michele; Ludwig, Heinz; Straka, Christian; Bringhen, Sara; Auner, Holger W.; Caers, Jo; Gramatzki, Martin; Offidani, Massimo; Dimopoulos, Meletios A.; Einsele, Hermann; Boccadoro, Mario; Sonneveld, Pieter; Engelhardt, Monika | |
CD38 as an immunotherapeutic target in multiple myeloma | 2018 | Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F. | |
Determining treatment intensity in elderly patients with multiple myeloma | 2018 | Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S. | |
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma | 2018 | Bringhen S.; D'Agostino M.; De Paoli L.; Montefusco V.; Liberati A.M.; Galieni P.; Grammatico S.; Muccio V.E.; Esma F.; De Angelis C.; Musto P.; Ballanti S.; Offidani M.; Petrucci M.T.; Gaidano G.; Corradini P.; Palumbo A.; Sonneveld P.; Boccadoro M. | |
Gentle yet effective combination therapy with novel agents in elderly multiple myeloma patients | 2018 | Larocca, Alessandra*; D'Agostino, Mattia; Boccadoro, Mario | |
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials | 2018 | D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F. | |
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma | 2018 | Oliva S.; Troia R.; D'Agostino M.; Boccadoro M.; Gay F. | |
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
Pursuing a curative approach in multiple myeloma: A review of new therapeutic strategies | 2019 | D'Agostino M.; Bertamini L.; Oliva S.; Boccadoro M.; Gay F. | |
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension | 2019 | Bringhen S.; Milan A.; D'Agostino M.; Ferri C.; Wasch R.; Gay F.; Larocca A.; Offidani M.; Zweegman S.; Terpos E.; Goldschmidt H.; Cavo M.; Ludwig H.; Driessen C.; Auner H.W.; Caers J.; Gramatzki M.; Dimopoulos M.A.; Boccadoro M.; Einsele H.; Sonneveld P.; Engelhardt M. | |
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma | 2019 | D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F. | |
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial | 2019 | Bringhen, Sara; D'Agostino, Mattia; Paris, Laura; Ballanti, Stelvio; Pescosta, Norbert; Spada, Stefano; Pezzatti, Sara; Grasso, Mariella; Rota-Scalabrini, Delia; De Rosa, Luca; Pavone, Vincenzo; Gazzera, Giulia; Aquino, Sara; Poggiu, Marco; Santoro, Armando; Gentile, Massimo; Baldini, Luca; Petrucci, Maria Teresa; Tosi, Patrizia; Marasca, Roberto; Cellini, Claudia; Palumbo, Antonio; Falco, Patrizia; Hájek, Roman; Boccadoro, Mario; Larocca, Alessandra | |
Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo | 2019 | Mattia D'Agostino; Mario Boccadoro | |
MODULATION OF THE IMMUNE MICROENVIROMENT IN MULTIPLE MYELOMA PATIENTS TREATED WITH DARATUMUMABBASED THERAPY: TUMOR CELL-EXTRINSIC EFFECTS OF DARATUMUMAB TREATMENT | 2020 | B. Castella, Mattia D’Agostino, C. Giannotta, S. Oliva, E. Genuardi, Milena Gilestro, M. Ruggeri, P. Corradini, B. Ziccheddu, F. Maura, S. Blasi, N. Bolli, A. Larocca, M. Boccadoro, M. Massaia. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile